Ireland· IE-PA-PA1963/012/002
Arquist 250 microgram per actuation pressurised inhalation, suspension
A fluticasone product containing fluticasone propionate, registered in Ireland by Cipla Europe. The same ATC class is registered in 16 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Fluticasone is registered in 16 of 19 countries.
Countries holding a registration under ATC R03BA05 (fluticasone), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Fluticasone · ATC R03BA05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Fluticasone propionate
- Manufacturer
- Cipla Europe
- Country
- Ireland (IE)
- ATC code
- R03BA05
- ATC class
- Fluticasone
- Defined daily dose
- 0.6 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1963/012/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
576 interactions on record for fluticasone.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fluticasone · interactions on record
576 records
- 35 severe
- 44 moderate
- 20 minor
- 475 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- MifepristoneG03XB01severe
- DesmopressinH01BA02severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fluticasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFlixotide 250micrograms/dose EvohalerDE Pharmaceuticals
- CzechiaFLIXOTIDE INHALER NGlaxoSmithKline Trading Services Limited, Dublin
- FinlandFlixotideGlaxo Operations UK Ltd.
- PolandFlixotideGlaxoSmithKline Trading Services Limited
- BelgiumFlutiform 250 µg - 10 µgMundipharma
- United States24 Hour Allergy NasalWalgreen Company
- SpainAVAMYS 27,5 mcg/PULVERIZACION PARA SUSPENSION NASALGlaxo Group Limited
- NetherlandsCortifil 0,5 mg/g crèmeLaboratorios SALVAT, S.A.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Flixonase Aquosum, Flixotide Diskus Forte
- Belgium · Flixonase Aqua, Flixotide
- Bulgaria · Аркуист, Фликсоназе
- Cyprus · Cutivate, Flixonase Aqueous
- Czechia · Flixotide Diskus, Flixotide Inhaler N
- Germany · Flutica, Fluticason Cipla
- Denmark · Flixotide, Flurhin
- Estonia · Cutivate Cream, Flixonase
- Spain · Avancort, Flixonase
- Finland · Flixonase, Flixotide Diskus
- France · Fixorinox, Flixonase
- United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
- Greece · Alerxem, Bocacort-S
- Croatia · Flixonase, Flixotide Inhaler
- Hungary · Cutivate, Flixonase
- Iceland · Avamys, Flixotide
- Italy · Aktanos, Deflut
- Liechtenstein · Avamys
- Lithuania · Cutivate, Flixotide
- Luxembourg · Flixonase Aqua, Flixotide
- Latvia · Flixonase, Flixotide
- Malta · Cutivate, Flihaler
- Netherlands · Cortifil, Cutivate
- Norway · Avamys, Flurhin
- Poland · Cutivate, Fanipos
- Portugal · Brisovent Diskus, Brisovent Inalador
- Romania · Arquist, Cutivate
- Sweden · Arquist, Fluticasone Cipla
- Slovenia · Flixonase, Flixotide
- Slovakia · Flixonase Aqueous, Flixotide Diskus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd3276b7-d394-47eb-879f-a95feac0eb69 GET /v1/drugs/cd3276b7-d394-47eb-879f-a95feac0eb69?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pressurised inhalation, suspension",
"routes": [
"Inhalation use"
],
"source": "hpra",
"atc_all": [
"R03BA",
"R03BA05"
],
"strength": null,
"pa_number": "PA1963/012/002",
"substances": [
"Fluticasone propionate"
],
"legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "13/01/2017",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about fluticasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.